Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia

Thommy Svahn, Karin Mellgren, Arja Harila-Saari, Ann Asberg, Jukka Kanerva, Olafur Jonsson, Goda Vaitkeviciene, Torben Stamm Mikkelssen, Kjeld Schmiegelow, Jesper Heldrup

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number26395
JournalPediatric Blood & Cancer
Volume64
Issue number7
Number of pages7
ISSN1545-5009
DOIs
Publication statusPublished - Jul 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • ALL
  • children
  • delayed methotrexate elimination
  • glucarpidase
  • CANCER-PATIENTS
  • RENAL DYSFUNCTION
  • THERAPY
  • GLUCARPIDASE
  • RESCUE
  • PHARMACOKINETICS
  • NEPHROTOXICITY
  • INTERVENTION
  • LEUCOVORIN
  • CLEARANCE
  • 3123 Gynaecology and paediatrics

Cite this